Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single Technology Appraisal
Year of publication: |
2012
|
---|---|
Authors: | Burch, Jane ; Griffin, Susan ; McKenna, Claire ; Walker, Simon ; Paton, James ; Wright, Kath ; Woolacott, Nerys |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 30.2012, 11, p. 991-1004
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Asthma | Beta-2-adrenergic-receptor-agonists | Children | Corticosteroids | Cost-effectiveness | Cost-utility | Decision-making | Omalizumab |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Single-Inhaler Combination Therapy for Asthma: A Review of Cost Effectiveness
Akazawa, Manabu, (2006)
-
Wilson, Edward C.F., (2010)
-
Wilson, Edward C.F., (2010)
- More ...
-
Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6–11 Years
Burch, Jane, (2012)
-
Faria, Rita, (2013)
-
Dronedarone for the Treatment of Atrial Fibrillation
McKenna, Claire, (2012)
- More ...